Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People

NCT00110812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

267

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: IL-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]